Meyer G J
Department of Psychology, University of Alaska Anchorage, USA.
J Pers Assess. 2000 Jun;74(3):356-70. doi: 10.1207/S15327752JPA7403_2.
A recent meta-analysis found that the Rorschach Prognostic Rating Scale (RPRS) had a strong ability to predict subsequent outcome (r = .44, N = 783; Meyer & Handler, 1997, this issue). However, that review did not directly address questions of incremental validity. This article focuses on the ability of the RPRS to predict outcome after taking into account other sources of data. Across studies that examined both the RPRS and the MMPI Ego Strength scale, the RPRS had a strong ability to predict outcome (r = .40, N = 187), whereas the MMPI scale did not (r = .02, N = 280). Nine studies examined the RPRS along with an intelligence test and allowed direct numerical estimates of incremental validity to be calculated. Across studies, the RPRS demonstrated strong incremental validity after controlling for intelligence (incremental r = .36, N = 358). It is clear that the Rorschach can make unique contributions to understanding clinically relevant processes in ways that self-reports or measured intelligence cannot. Contemporary Rorschach scales should continue to be evaluated for their distinctive and incremental contribution to clinical practice.
最近的一项荟萃分析发现，罗夏预后评定量表（RPRS）具有很强的预测后续结果的能力（r = 0.44，N = 783；迈耶 & 汉德勒，1997年，本期）。然而，该综述并未直接涉及效度增量的问题。本文重点关注在考虑其他数据来源后，RPRS预测结果的能力。在同时检验RPRS和明尼苏达多相人格调查表（MMPI）自我力量量表的研究中，RPRS具有很强的预测结果的能力（r = 0.40，N = 187），而MMPI量表则不然（r = 0.02，N = 280）。九项研究将RPRS与一项智力测验一起进行检验，并允许计算效度增量的直接数值估计。在各项研究中，在控制智力因素后，RPRS显示出很强的效度增量（增量r = 0.36，N = 358）。显然，罗夏测验能够以自我报告或测得的智力所无法做到的方式，为理解临床相关过程做出独特贡献。当代罗夏测验量表应继续接受评估，以确定它们对临床实践的独特和增量贡献。
